A recent report published by Infinium Global Research on the anti-malarial drugs market provides in-depth analysis of segments and sub-segments in the global as well as regional anti-malarial drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional anti-malarial drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of the global anti-malarial drugs market. According to the report, the global anti-malarial drugs market is projected to reach USD 1157.3 million by 2027 from USD 895.1 million in 2021, growing at a CAGR of 4.37% over the forecast period of 2021-2027.
Malaria is an infectious disease, which spreads through a bite of an infected female Anopheles mosquito, transferring parasites into the human body. There are basically five different types of plasmodia parasites that cause malaria in human bodies. After entering the body these parasites attack the liver cells which later on multiply and start growing within the body. They move in the red blood cells to reach a stage called the merozoites. Furthermore, these merozoites later grow inside the red cells and destroy them further causing symptoms such as fever, tiredness, vomiting, headache etc. Antimalarial drugs are basically being used in the treatment and prevention of this infectious disease. Malaria is majorly found in tropical regions such as Central and South America, Africa, Asia, the Middle East, and some Pacific islands.
As most of the governments in various countries are focusing on the treatment of covid 19 so the major players in the market to increase the exports of hydroxychloroquine which drive to contribute to the market growth in the near future. The two major players in the market such as Ipca Laboratories and Zydus Cadila produce over 1.5 million tablets on a daily basis. The hydroxychloroquine segment is anticipated to hold a significant share over the forecasting years. Few African countries still don’t have good healthcare infrastructures, due to which there is a lack of awareness within the population about healthcare factors that can affect the growth of the Anti-malarial Drugs Market. The increasing preference for hydroxychloroquine as a medication for coronavirus disease will boost the market growth in the coming years
Among the regions, the Middle East and Africa have been accounted for the major market share and are expected to continue this trend, owing to a rapid surge in the prevalence of malaria, availability of diagnostic tests for the disease in the region. However, the Asia Pacific region is anticipated to grow with the highest rate in the global anti-malarial drugs market over the forecast period. The growth is due to owing to increasing regulatory approval of the products, and the presence of major pharmaceutical companies in large economic countries such as Japan, China, India, etc.
The report on global anti-malarial drugs market covers segments such as drug class, route of administration, and distribution channel. On the basis of drug class, the sub-markets include quinine, chloroquine, proguanil, mefloquine, pyrimethamine, and others. On the basis of route of administration, the sub-markets include oral, and injectable. On the basis of distribution channel, the sub-markets include hospital pharmacy, retail pharmacy, e-commerce, and others.
The report provides profiles of the companies in the market such as Pfizer Inc., Sun Pharmaceutical Industries Ltd, Zydus Cadila, Alvizia Healthcare Pvt. Ltd, GlaxoSmithKline Plc, Hoffmann-La Roche Ltd, Novartis AG, Bayer AG, Ipca Laboratories Ltd, and Merck KGaA.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of anti-malarial drugs market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.